iCAD Overview

  • Founded
  • 1984
Founded
  • Status
  • Public
  • Employees
  • 114
Employees
  • Stock Symbol
  • ICAD
Stock Symbol
  • Investments
  • 8
  • Share Price
  • $6.09
  • (As of Friday Closing)

iCAD General Information

Description

icad Inc provides cancer detection, radiation therapy and workflow solutions, primarily computer-aided detection and workflow solutions for breast, prostate and colorectal cancers. Its products include powerlook tomo detection, powerlook density assessment, and vera look. The firm has also developed a technology namely Xoft Axxent electronic brachytherapy system used in the treatment of non-melanoma skin cancer, early-stage breast cancer, and gynecological cancers.

Contact Information

Website
www.icadmed.com
Formerly Known As
Howtek
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Services
Other Industries
Laboratory Services (Healthcare)
Stock Exchange
NAS
Primary Office
  • 98 Spit Brook Road
  • Suite 100
  • Nashua, NH 03062
  • United States
+1 (603) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

iCAD Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.09 $6.19 $5.27 - $21.44 $153M 25.1M 208K -$0.36

iCAD Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 232,744 290,708 153,323 61,338
Revenue 36,281 29,698 31,340 25,621
EBITDA (7,981) (16,715) (12,554) (8,065)
Net Income (8,702) (17,610) (13,551) (9,017)
Total Assets 65,737 55,582 41,748 31,737
Total Debt 1,287 8,761 22,490 13,101
Public Fundamental Data provided by Morningstar, Inc. disclaimer

iCAD Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore iCAD‘s full profile, request access.

Request a free trial

iCAD Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
icad Inc provides cancer detection, radiation therapy and workflow solutions, primarily computer-aided detection and wor
Other Healthcare Services
Nashua, NH
114 As of 2020
000.00
000000000 000.00

000000 0

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
00000 0000000000 00000000
London, United Kingdom
000 As of 0000
00000
00000000000 00000

0000000

nim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
0000000000 000000000
Sunnyvale, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

iCAD Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vision RT Formerly VC-backed London, United Kingdom 000 00000 00000000000 00000
0000000 Formerly VC-backed Sunnyvale, CA 000 00000 000000 - 000 00000
0-0000 Venture Capital-Backed Shilat, Israel 00 0000 0000000000 0 0000
000000 0000000 000 Private Equity-Backed Littleton, MA 000 00000 0000000 0000 00000
0000000 Formerly VC-backed Oakwood, OH 000 00000 00000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

iCAD Patents

iCAD Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019384179-A1 System and method for assessing breast cancer risk using imagery Pending 23-Nov-2018 0000000000
EP-3884458-A1 System and method for assessing breast cancer risk using imagery Pending 23-Nov-2018 0000000000
US-20200167920-A1 System and method for assessing breast cancer risk using imagery Pending 23-Nov-2018 0000000000
US-20170079604-A1 System and method for digital breast tomosynthesis Abandoned 18-Sep-2015 000000000
JP-6564018-B2 Radiation image lung segmentation technology and bone attenuation technology Active 08-Apr-2014 G06T3/0093
To view iCAD’s complete patent history, request access »

iCAD Executive Team (13)

Name Title Board Seat Contact Info
Stacey Stevens Chief Executive Officer & President
Charles Carter Interim Chief Financial Officer
Jonathan Go Chief Technology Officer, Technology
Brian Testa Chief People Officer
You’re viewing 4 of 13 executive team members. Get the full list »

iCAD Board Members (13)

Name Representing Role Since
000000 0000000 Self Board Member 000 0000
00000000 000000 00 Self Board Member 000 0000
0000000 00000 iCAD Chairman & Board Member 000 0000
000000000 000000 00 iCAD Director and Senior Advisor for Affiliated Managers Group, Inc 000 0000
000000 00000 00 Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

iCAD Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

iCAD Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 13-Jan-2016 0000000000 00000 Monitoring Equipment 0000000 0
000000 (00000 29-Apr-2015 0000000000 00.00 Diagnostic Equipment 0000000 0
0000000 15-Jul-2014 0000000000 000 Therapeutic Devices 0000000 0
000000 15-Jul-2014 0000000000 00.00 Other Healthcare Technology Systems 0000000 0
Xoft 30-Dec-2010 Merger/Acquisition 000.00 Surgical Devices 0000000 0
You’re viewing 5 of 8 acquisitions. Get the full list »

iCAD Subsidiaries (2)

Company Name Industry Location Founded
Xoft Surgical Devices San Jose, CA 1998
000000 000000000 Hospitals/Inpatient Services Beavercreek, OH 0000
To view iCAD’s complete subsidiaries history, request access »